- Home
- united kingdom
- Companies
Refine by
Medical Industry Technology In United Kingdom
31 companies found
Technologybased inFairfield, CONNECTICUT (USA)
GE is Imagination at work. From jet engines to power generation, financial services to water processing, and medical imaging to media content, GE people worldwide are dedicated to turning imaginative ideas into leading products and services that ...
Technologybased inCambridge, UNITED KINGDOM
Based in Cambridge, one of Europe's largest bioscience hubs, Biorbyt has a simple yet challenging mission: to provide the best service to the global scientific community. We achieve this by collaborating with the world’s finest researchers and ...
Monoclonal antibodies; one of the most widely used tools in biological research, with the potential soon to become important therapeutics, have been with us for just over 40 years. These antibodies are monovalent, bind to a single epitope and are ...
Technologybased inCambridge, UNITED KINGDOM
GW is the global leader in developing cannabinoid-based medicines. GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics. GW has established a world ...
Many of the childhood-onset intractable epilepsy conditions within the expanded access program share considerable overlap with ASD and these conditions often fall within the orphan disease space. Initial clinical observations from treating ...
Technologybased inCambridge, UNITED KINGDOM
Lightcast is developing a cell manipulation platform that utilises tiny spots of light to control thousands of cells and reagents at once, enabling game-changing workflows for the pharmaceutical industry. With applications ranging from ...
Finding rare events: The Lightcast platform is designed to have a high throughput and will be ideally suited to finding one in 10,000 or one in 100,000 ...
Technologybased inNorwich, UNITED KINGDOM
We are a passionate and skilled drug discovery and development biotech team developing an innovative new class of oligonucleotide antimicrobial agents. Procarta is currently working on lead optimisation for its first product, a narrow-spectrum agent ...
Proprietary nanoparticles deliver an oligonucleotide inside the bacterial pathogen. The oligonucleotide acts as a Transcription Factor Decoy (TFD): it contains the binding site of a transcription factor that controls a large set of genes required ...
Technologybased inEdinburgh, UNITED KINGDOM
Extra-corporeal treatments like dialysis, cardiopulmonary bypass, and ECMO involve the circulation of the patient's blood supply through a machine. The patient's immune system treats the machine as a large, unwanted foreign body; the resulting ...
Human pathogenic bacteria have evolved an "invisibility cloak" which allows them to go undetected by the human immune system. This "invisibility cloak" is similar to what our own cells use to avoid immune ...
Technologybased inCambridge, UNITED KINGDOM
We’re driven by the shared purpose of breaking new ground in the discovery of new treatments for rare diseases. Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to ...
Our Rare Treatment Accelerator helps academic, patient, and industry groups advance their rare disease drug redevelopment projects. By combining our team, expertise and financial resources with your research and insights, we can get treatments to ...
Technologybased inAlcester, UNITED KINGDOM
Quanta Dialysis Technologies is making dialysis more accessible to every patient in every setting with its SC+ hemodialysis system. SC+ is an end-to-end solution with performance comparable to a large traditional machine, and all the flexibility you ...
Technologybased inLondon, UNITED KINGDOM
Embody is a spin-out company from Imperial College London. We are a team of specialists from a variety of engineering, medical, and design backgrounds. Embody provides pre-operative planning, patient specific instruments and complex surgical ...
The H1 is a contoured ceramic-on-ceramic hip resurfacing arthroplasty system. It consists of two monoblock implant components (femoral head and acetabular cup) made of BIOLOX®delta with vacuum-plasma-sprayed titanium and hydroxyapatite for ...
Technologybased inSt. Louis, MISSOURI (USA)
Emerson has boldly transformed to create value for our customers and shareholders. With our newly energized focus on our two core business platforms — Automation Solutions and Commercial & Residential Solutions — we can confront the challenges of an ...
The CT3204 pMDI Leak Detection and Reject System, primarily used for pharmaceutical applications, provides customers with a step-change in capability over existing test methods. Manufacturers of metered dose inhalers are required by the FDA to test ...
Technologybased inOxford, UNITED KINGDOM
Vaccitech is a clinical stage T cell immunotherapy and vaccine company developing products to treat and prevent infectious disease and cancer. The company’s proprietary heterologous prime-boost platform comprises Chimpanzee Adenovirus Oxford ...
The patented Vaccitech adenovirus vectors are known as chimpanzee adenovirus Oxford 1 and 2 (ChAdOx1 and ChAdOx2), and are in the group E simian adenovirus family, similar to the widely-studied chimpanzee adenovirus 63. These viruses have been ...
Technologybased inBirmingham, UNITED KINGDOM
Our experienced board and management team guides Linear Diagnostics to maximise the opportunites that are emerging within the healthcare and diagnostic markets. The company’s board and management team comprises experienced medical diagnostics ...
Initially focused on sexually transmitted infections, the technology can be utilised in a wide range of diagnostic applications. Based on market opportunity, Linear Diagnostics concluded that a dual test for Chlamydia trachomatis and Neisseria ...
Technologybased inLondon, UNITED KINGDOM
Founded in 2015, the original idea behind Airfinity was to systematically capture and structure the new science disseminated at conferences, a highly fragmented dataset. However, through working with medical associations and pharma companies, ...
The market leading platform for Infectious Disease Analytics (IDA), supporting decision making across the life science ecosystem track, analyse, simulate and predict disease ...
Technologybased inCambridge, UNITED KINGDOM
Nuclera is the pioneer in bringing rapid protein prototyping to the benchtop. We make proteins accessible through eProtein DiscoveryTM. Through our technology, we accelerate breakthrough improvements in human health and empower life science ...
Technologybased inClydach, UNITED KINGDOM
Our cutting-edge technology is transforming the market with the incredible potential of microalgae, offering sustainable and eco-friendly solutions for a brighter future. At API, we have mastered the art of separating algae and harnessing its full ...
Discover Beta-Carotene, a natural pigment and carotenoid compound sourced from a diverse range of microalgae. Renowned for its vibrant orange or red hues, Beta-Carotene holds remarkable significance. As a precursor to vitamin A, this provitamin A ...
Technologybased inExeter, UNITED KINGDOM
Attomarker is a British company focused on nanophotonic biochemical testing. It was founded in 2008, and spun out from Professor Andrew Shaw’s research group at the University of Exeter. It has won numerous prestigious awards for innovation and been ...
Attomarker has developed a technology platform that will measure the concentration of biomarkers in blood samples, but it can be readily extended to saliva or even cerebral spinal fluid. The blood contains many components – biomarkers – ...
Technologybased inOxford, UNITED KINGDOM
Orthonika is a spin-out company from Imperial College London. It is the result of a collaboration between Imperial College and Sierra MedTech and aims to develop and commercialise a novel anatomical Total Meniscus Replacement. We are combining world ...
Orthonika's Total Meniscus Replacement is based on a unique design and proprietary high strength polymers and constructions which replicates not only the bulk macroscopic geometry of the meniscus, but also the underlying microstructure and ...
Technologybased inCheshire, UNITED KINGDOM
Founded in 2012 at University of Manchester, Gelmetix is a UK medtech company focused on treating chronic lower back pain caused by the degeneration of the intervertebral discs. Gelmetix’s polymer gel technology also has the potential to be adapted ...
A focus on low-back pain. About 40% of chronic low-back pain is the result of degenerative disc disease3. Gelmetix’s double cross-linked microgel (DXM) is a biological solution that addresses the source of pain. In the intervertebral disc it ...
Technologybased inEdinburgh, UNITED KINGDOM
Edinburgh Molecular Imaging is a clinical phase biotechnology company focused on enabling image guided interventional medicine. The company´s molecular targetting technology has the potential to tackle disease in real-time to allow interventional ...
Technologybased inCambridge, UNITED KINGDOM
Founded by Dr Mark Kotter and Florian Schuster, bit.bio is an award-winning human synthetic biology enterprise. bit.bio™s mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to ...
